HPV vaccination: key factors studied
R. PRASAD High cost to treat cancer engenders willingness to pay for vaccine A formative study was completed recently to understand the various facets of the society and health systems prior to introducing a vaccine that can prevent Human papillomavirus (HPV) infection that is responsible for causing cervical cancer in women.
Related Content
- Biomarkers of environmental enteropathy are positively associated with immune responses to an oral cholera vaccine in Bangladeshi children
- Livestock farmers’ participation and factors affecting the success of animal health care program in hill region
- World cancer cases to rise by 75 percent by 2030
- Efficient mitigation strategies for epidemics in rural regions
- WHO-recommended steps against tobacco epidemic stressed
- TB tangle